We narrowed to 6,614 results for: human c myc
-
Plasmid#169320PurposeGateway entry vector for human VPS4B ORFDepositorAvailable SinceMay 11, 2021AvailabilityAcademic Institutions and Nonprofits only
-
pENTR D-TOPO-C3_9
Plasmid#60258PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertNKX6-1 enhancer (NKX6-1 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_10
Plasmid#60259PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertRFX6 enhancer (RFX6 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_25
Plasmid#60268PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertROCK1 enhancer (ROCK1 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
p3E-BIN1_tv8
Plasmid#126574PurposeMultisite gateway middle entry vector containing human BIN1 transcriptional variant 8 (muscle specific) with no ATG. Parton lab clone DVA.DepositorInsertBIN1 (BIN1 Human)
UseGateway entry cloneAvailable SinceNov. 4, 2021AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_7
Plasmid#60256PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertSLC30A8 enhancer (SLC30A8 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_17
Plasmid#60263PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertZFAND3 enhancer (ZFAND3 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_18
Plasmid#60264PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertZBED3 enhancer (ZBED3 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_19
Plasmid#60265PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertTHADA enhancer (THADA Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_22
Plasmid#60267PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertZMIZ1 enhancer (ZMIZ1 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_26
Plasmid#60269PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertOBFC2A enhancer (NABP1 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_31
Plasmid#60273PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertSLC2A2 enhancer (SLC2A2 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C3_34
Plasmid#60276PurposeThis plasmid contains a human pancreatic islet active enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertPNMA2 enhancer (PNMA2 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_11
Plasmid#60251PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertSMYD3 inactive enhancer (SMYD3 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pENTR D-TOPO-C2_13
Plasmid#60252PurposeThis plasmid contains a human pancreatic islet inactive enhancer, which can be shuttled into a Gateway destination vector, such as pGL4.23-Gateway.DepositorInsertSPATA19 inactive enhancer (SPATA19 Human)
UseEntry vectorAvailable SinceDec. 2, 2014AvailabilityAcademic Institutions and Nonprofits only -
pHTC-HaloTag_DDB1:1-1140
Plasmid#211007PurposeMammalian expression of full-length human DDB1. C-terminal HaloTag.DepositorAvailable SinceFeb. 21, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
pHTC-HaloTag_SUZ12:1-739
Plasmid#211010PurposeMammalian expression of full-length human SUZ12. C-terminal HaloTag.DepositorInsertSUZ12:M1-L739 (SUZ12 Human)
TagsHaloTagExpressionMammalianMutationwild typePromoterCMVAvailable SinceFeb. 21, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
pHTC-HaloTag_C9orf72:1-481
Plasmid#210987PurposeMammalian expression of full-length human C9orf72. C-terminal HaloTag.DepositorInsertC9orf72:M1-F481 (C9orf72 Human)
TagsHaloTagExpressionMammalianMutationwild typePromoterCMVAvailable SinceFeb. 21, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
pHTC-HaloTag_FBXO3:1-471
Plasmid#211072PurposeMammalian expression of full-length human FBXO3. C-terminal HaloTag.DepositorInsertFBXO3:M1-F471 (FBXO3 Human)
TagsHaloTagExpressionMammalianMutationwild typePromoterCMVAvailable SinceMarch 19, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
pHTC-HaloTag_RAB7A:1-207
Plasmid#211096PurposeMammalian expression of full-length human RAB7A. C-terminal HaloTag.DepositorInsertRAB7A:M1-C207 (RAB7A Human)
TagsHaloTagExpressionMammalianMutationwild typePromoterCMVAvailable SinceMarch 19, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits